Literature DB >> 6435011

Thyrotropin-releasing hormone in experimental spinal injury: dose response and late treatment.

A I Faden, T P Jacobs, M T Smith.   

Abstract

Early treatment with thyrotropin-releasing hormone (TRH) at high doses improves neurologic recovery from experimental spinal injury in cats. We have now compared the effects of TRH dose and time of treatment on neurologic outcome. TRH-treated animals showed better motor recovery than saline controls; effects were dose-related (between 0.02 mg/kg/hr and 2.0 mg/kg/hr), with significant effects even at the lowest dose. Cats treated at 24 hours after injury also improved significantly. These findings provide additional support for TRH trials in human spinal injury and suggest that even late treatment may be effective.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435011     DOI: 10.1212/wnl.34.10.1280

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Single-compartment model analysis of thyrotropin-releasing hormone kinetics in hyper- and hypothyroid patients. Kinetic studies using a combined system of RIA and FPLC.

Authors:  L Duntas; F S Keck; J Rosenthal; C Wolf; U Loos; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1990-10-17

2.  Glycine: an important potential component of spinal shock.

Authors:  R K Simpson; C S Robertson; J C Goodman
Journal:  Neurochem Res       Date:  1993-08       Impact factor: 3.996

Review 3.  Multifunctional drug treatment in neurotrauma.

Authors:  Bogdan Stoica; Kimberly Byrnes; Alan I Faden
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 4.  Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers.

Authors:  Abhay K Varma; Arabinda Das; Gerald Wallace; John Barry; Alexey A Vertegel; Swapan K Ray; Naren L Banik
Journal:  Neurochem Res       Date:  2013-03-06       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.